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We describe a case of Salmonella enteritidis infection of a prosthetic knee joint that was
cured with ceftriaxone therapy for 6 weeks and replacement of the tibial component of the
prosthesis. Eleven other cases of salmonella prosthetic joint infection have been reported
in the English-language literature. Five infections occurred within 20 days of prosthesis
placement, and seven occurred several months to years later; ten of 12 infections involved
hip prostheses. Nine of 12 patients who had prosthesis removal were cured of the
infection. Two of the three patients with retention of the prosthesis required long-term
suppressive antibiotic therapy.
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Septic arthritis is a rare consequence of salmonella
bacteremia, usually occurring in patients with
underlying medical conditions, such as sickle cell
disease and systemic lupus erythematosus (SLE)
[1]. Less commonly, Salmonella species have been
reported to cause prosthetic joint infections [2–9].
We report a case of Salmonella enteritidis infection
of a prosthetic knee joint. The infection was cured
with antibiotic therapy and partial replacement of
the prosthesis.
C A S E R E P O R T
A 55-year-old-man presented with a 2-day history
of fever and right knee pain. The patient had a
right total knee arthroplasty performed 12 days
prior to the onset of his symptoms. His past med-
ical history was significant for type II diabetes
mellitus, hypertension, and osteoarthritis.
On admission, his temperature was 39.7 8C,
blood pressure 116/60 mmHg, and pulse 120
beats/min. The right knee was swollen, tender,
and warm, and had decreased range of motion.
The incision site was healed without evidence of
purulent drainage. Laboratory studies revealed:
white blood cell (WBC) count 18.1 109/L, with
74% neutrophils, hemoglobin 122 g/L, and Wester-
gren erythrocyte sedimentation rate (WESR) 106
mm/ h. Aspiration of the right knee joint yielded
10 mL of bloody fluid containing 0.67 1012 red
blood cells (RBC)/L and 27.9 109 WBC/L, with
94% neutrophils. Gram stain did not reveal any
microorganisms. Empirical therapy with intrave-
nous cefazolin was initiated.
On the fifth hospital day, the knee joint was
again aspirated. The fluid showed 118 109 WBC/
L, with 95% neutrophils, and 0.42 1012 RBC/L.
The glucose level was 0.17 mmol/L (3 mg/dL). On
that day, the initial culture of the joint fluid was
reported to be growing S. enteritidis, resistant only
to ampicillin. Cefazolin was changed to ceftriax-
one, 2 g daily, and the knee was surgically
explored. No grossly purulent material was found,
and all the installed components of the knee were
intact. The tibial polyethylene component was
removed. The joint was irrigated with saline with
added gentamicin, a complete synovectomy was
performed, and a new polyethylene tibial compo-
nent was inserted. Synovial tissue yielded S. enter-
itidis.
Postoperatively, there was minimal drainage
and swelling. By the seventh hospital day, the
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patient was afebrile, the WBC count had fallen to
9.9 109/L, and the WESR had fallen to 84 mm/ h.
Multiple cultures of blood, urine, and stool did not
reveal S. enteritidis. Ultrasound of the abdomen
showed no cholelithiasis or other abnormalities of
the gall-bladder or liver. The patient received a
total of 6 weeks of ceftriaxone therapy; the WESR
returned to normal, and clinical improvement
continued. No oral suppressive antibiotics were
used. Follow-up over the ensuing 6 years showed
no recurrence of infection; the knee had only 808 of
flexion, but full extension was attained.
D I S C U S S I O N
Septic arthritis is a rare consequence of salmonella
bacteremia, noted in <1% of cases in several large
reviews of salmonellosis [10]. Similarly, reviews of
Gram-negative bacillary arthritis rarely mention
Salmonella as a cause of septic arthritis [11], and it is
even more uncommon as a cause of prosthetic joint
infection [2–9]. In developing countries, septic
arthritis due to Salmonella is encountered more
frequently and is mostly an infection of young
children [12].
Including the present case, only 12 patients with
prosthetic joint infections due to Salmonella have
been reported in the English-language literature
[2–9] (Table 1). Ten of the 12 cases involved
infected hip prostheses; only one infected pros-
thetic knee was reported prior to the present case
[9]. Patients with native joint infections with Sal-
monella often have underlying problems with mal-
nutrition [12], sickle cell disease [13], collagen
vascular diseases [1,14], or other immunosuppres-
sive diseases [4,15]. However, only one patient
with prosthetic joint infection due to Salmonella
had sickle cell trait [8], and none had SLE. Most of
the patients had no underlying illnesses, except for
osteoarthritis or prior trauma to the joint, which
prompted the placement of the prosthesis.
The usual pathogenesis of salmonella septic
arthritis is thought to be hematogenous, spread
from the gastrointestinal tract, rather than direct
inoculation into the joint. We assumed that our
patient had acute salmonella gastroenteritis with
bacteremia, which seeded the newly placed knee
prosthesis. He later remembered having eaten
some pork that tasted ‘bad’ and developing diar-
rhea a few days prior to admission; whether this
was related to his subsequent infection is not clear.
Only four of the 11 previously reported patients
with prosthetic joint infection had an episode of
diarrhea prior to the onset of arthritis [2,5,6]. Five
patients, including the present case, had onset of
septic arthritis in the immediate postoperative
period [5,6].
The symptoms and signs of prosthetic joint
infection due to Salmonella did not differ from
those of infections due to other Gram-negative
bacilli. Systemic symptoms of fever, chills and
malaise were common. The most prominent symp-
tom was joint pain; erythema, swelling, and
warmth were present to a variable degree. Drai-
nage and fistula formation were seen only in those
patients in whom long-term antibiotic therapy was
given without removal of the prosthesis [5,6].
Joint fluid findings have been noted infre-
quently. When described, joint fluid was either
cloudy or purulent [3,6,8,9]. WBC counts and
Gram stain findings have not been reported
among those with prosthetic joint infection. Our
patient had non-purulent fluid aspirated initially,
although a subsequent aspirate was purulent; no
organisms were visible on Gram stain.
Treatment of prosthetic joint infections often
requires removal of the prosthetic components
[16–18]. Our prior experience in an elderly popu-
lation with infected prostheses showed a dismal
outcome unless the prosthesis was removed [16].
However, others have reported eradication of
infection with prosthesis retention, especially in
the setting of early prosthetic joint infection, when
prompt surgical debridement and appropriate
antibiotic therapy were given [17,18]. Overall, nine
of 12 patients with salmonella prosthetic joint
infection required prosthesis removal. Our
patient had a successful outcome with removal
and immediate replacement of one component
of the joint, even though the site still yielded
Salmonella.
Antibiotic choices for salmonella arthritis
include ampicillin, chloramphenicol, trimetho-
prim–sulfamethoxazole, third-generation cepha-
losporins, and ciprofloxacin. Given the increasing
rate of resistance among Salmonella strains, ther-
apy should be guided by in vitro susceptibility
studies. A cogent argument can be made for the
use of a fluoroquinolone as the preferred agent for
treatment of prosthetic joint salmonella infection,
given the ability of this class of drugs to kill not
only rapidly growing bacteria, but also those bac-
teria that are in a stationary phase and adherent to
the prosthetic material [7].
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Table 1 Prosthetic joint infections due to Salmonella: review of the English-language literature
Ref. Age/Sex
Underlying
conditions
Joint/postoperative
time
Salmonella
species Therapy Outcome
[2] 42/F Post-traumatic
osteonecrosis
Hip/3.5 year newport Chloro, Amp,
TCN 2 year;
prosthesis
removal
Cured
[3] 67/F Osteoarthritis Hip/9 month typhimurium Amp;
prosthesis
removal
Cured
[4] 40/M Osteoarthritis Hip/1 year typhimurium Amp;
prosthesis
removal
Cured
[5] 70/M Osteoarthritis Hip/20 days dublin Cephalexin,
TMP/SMX;
prosthesis
retained
Recurred
with sinus
tract on
chronic
TMP/SMX
[6] 69/M Osteoarthritis;
appendectomy
6 months
before hip
Hip/4 days typhimurium Gentamicin;
prosthesis
removal
Cured
[6] 71/M Traumatic
fracture
Hip/3 days typhimurium Cephalothin,
gentamicin
TMP/SMX;
prosthesis
removal
Cured
[6] 24/F Familial
Mediterranean
Fever
Hip/6 days typhimurium TMP/SMX;
prosthesis
retained
Cured
[6] 43/M Ankylosing
spondylitis,
prior salmonella
gastroenteritis
Hip/4 years muenchen TMP/SMX;
prosthesis
removal
Cured
[7] 42/M Renal transplant
recipient,
avascular
necrosis
Hip/8 years dublin Amox,
TMP/SMX;
prosthesis
removal and
replacement
Recurred,
resolution
following
Cipro for
1 year
[8] 51/M Diabetes
mellitus, HIV,
sickle cell
trait,
post-traumatic
osteonecrosis
Hip/9 years hirschfeldii Chloro, Amp,
TMP/SMX,
Oflox 2.5 years;
prosthesis
removal and
replacement
Cured
[9] 67/F Rheumatoid
arthritis
Knee/5 years typhimurium Chloro, Amox,
gentamicin;
prosthesis
retained
Cured,
chronic
Amox
PR 55/M Diabetes
mellitus,
osteoarthritis
Knee/12 days enteritidis Ceftriaxone
6 weeks;
replacement
of tibial
component
Cured
Chloro, chloramphenicol; Amp, ampicillin; TCN, tetracycline; TMP/SMX, trimethoprim–sulfamethoxazole; Amox,
amoxicillin; Cipro, ciprofloxacin; Oflox, ofloxacin; PR, present report.
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Septic arthritis in native joints due to Salmonella
appears to have a good prognosis. Recovery of arti-
cular function is superior to that following infection
with staphylococci and most other Gram-negative
organisms [1,4]. Our case emphasizes the potential
to cure salmonella prosthetic joint infection by
utilizing prompt debridement, early component
replacement, and appropriate antibiotics.
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